Location History:
- Tsukuba, JP (2005 - 2007)
- Ibaraki, JP (2003 - 2010)
- Tokyo, JP (2015 - 2018)
Company Filing History:
8 out of 417 
3 out of 329 
2 out of 3 Years Active: 2003-2018
Title: Masazumi Kamohara: Innovator in Anti-Human Tie2 Antibody Research
Introduction
Masazumi Kamohara is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of 11 patents to his name, Kamohara's work focuses on innovative solutions for treating serious health conditions.
Latest Patents
One of Kamohara's latest patents is an anti-human Tie2 antibody designed to prevent or treat diabetic macular edema, diabetic retinopathy, and critical limb ischemia. This antibody works by binding to human Tie2, thereby activating it. The invention includes a detailed composition of the antibody, which comprises four heavy chain variable regions and four light chain variable regions. The heavy chain variable region consists of the amino acid sequence of the amino acid numbers 1 to 122 of SEQ ID NO: 2, while the light chain variable region consists of the amino acid sequence of the amino acid numbers 1 to 113 of SEQ ID NO: 4. Each heavy chain variable region and light chain variable region together form one antigen-binding site, resulting in an antibody with four antigen-binding sites.
Career Highlights
Throughout his career, Kamohara has worked with notable companies in the pharmaceutical industry. He has been associated with Astellas Pharma GmbH and Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research and development projects. His expertise in antibody research has positioned him as a key figure in the field.
Collaborations
Kamohara has collaborated with several professionals in his field, including Jun Takasaki and Mitsuyuki Matsumoto. These collaborations have further enhanced his research and development efforts, leading to innovative solutions in biotechnology.
Conclusion
Masazumi Kamohara's work in developing anti-human Tie2 antibodies showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of serious health conditions, making him a noteworthy inventor in the field of biotechnology.